Larry Mickelberg

After months of work…my new book Launchcode is live. It’s not just a book, it’s a blueprint for AI-native, agentic pharma commercialization. Inspired by the vision we’re building at @AxonalAI. Now available on Amazon, Barnes & Noble & more. amazon.com/author/lfm

The End of the Plan. An Axonal AI POV. linkedin.com/posts/larrymick…

I just published Pharma Has More AI Than Ever. Why Are Launches Still Failing? medium.com/p/pharma-has-more…

Most pharma commercial AI is a faster way to do the same thing. @Axonal_AI is decision infrastructure. Decision Objects capture the decision: context, evidence, reasoning, trade-offs, outcomes, actions. Structured. Traceable. Reusable. Built on decision science, not vibes.

Dashboards don’t decide. Slides don’t adapt. Teams don’t move fast enough. #AgenticAI changes the operating model. I wrote Launchcode for leaders who see what’s breaking and want a path forward. 📘 amazon.com/Launchcode-Pharma… #PharmaAI #Innovation #Leadership

AI is rewriting pharma’s power dynamics. Biotechs are getting the edge. Read why: 🔗 linkedin.com/pulse/ai-flippi… #AI #Pharma #Biotech @Axonal_AI

Stoked to see @Axonal_AI included in @MMMnews's list of AI pharma marketing tools that clients say actually work. Less hype. More impact. Built for real commercial decisions in regulated environments. 👉 mmm-online.com/news/5-ai-pha… #AxonalAI #Pharma #AIThatWorks #LifeSciences

Check out my latest article: The Future of Pharma Commercialization is Agentic linkedin.com/pulse/future-ph… via @LinkedIn

Cannes FOMO is real. The energy, the ideas, the people. I’ve always loved it. But this year, my focus is here: building at Axonal.AI, scaling agentic systems, and getting ready to launch my new book Launchcode. Pre-orders drop soon. Let’s go.

Dashboards don’t scale. Intelligent systems do. Mary Meeker shows how fast AI has gone global. At @Axonal_AI, our agents deliver localized insights with enterprise reach. Structured + unstructured. Regional + real-time. Decision-ready. linkedin.com/posts/larrymick…

Most companies are using AI to grow, not just cut costs. Mary Meeker’s report backs it up: 📈 Revenue ⚡ Productivity 🤝 CX That’s the focus at @Axonal_AI. Our agents help pharma teams act on what matters now.

AI is no longer an experiment. 🔹 6x growth in devs (NVIDIA) 🔹 $212B AI CapEx 🔹 Over 50% of S&P 500 now talk AI on earnings calls Pharma can’t afford to stay in pilot mode. At @Axonal_AI, we’re building AI agents that plug into real workflows.

AI adoption is moving faster than any tech wave before it. 💡 ChatGPT hit 365B annual searches in 2 years. Google took 11. At @Axonal_AI, we’re not just watching. We’re building for it. Intelligent agents. Real decisions. Commercial speed.

The @WSJ recently spotlighted a major shift: AI agents that collaborate — not just automate. In a new post, I break down how we are building multi-agent orchestration for smarter, faster pharma commercialization at Axonal.AI linkedin.com/posts/larrymick…

Veeva just launched Veeva AI - agents and shortcuts. Launch? Dec 2025. Pharma can’t wait. Teams are stretched. Work’s slow. Insights stuck. AI isn’t coming. It’s here. Axonal.AI is faster, lighter—built for life sciences. The future is for movers. Let’s go.

Companies building compliance into pharma development from day one are seeing 30% faster time-to-market. Gone are the days of treating regulations as hurdles - they're now strategic accelerators. What's your take on compliance-by-design? 🤔 #Pharma #Innovation

📊 McKinsey data: Companies investing 20% in business building see 2% higher growth. For pharma, AI-driven capabilities are now essential. @AxonalAI helps accelerate commercialization by 30% while maintaining compliance. Transform your operations: axonal.ai

Amazon's building 1000+ AI apps including health tools with clinical verification. Meanwhile, pharma hesitates. @Axonal_AI proves AI & compliance can coexist, helping pharma transform drug commercialization. The future is here - what's holding you back? #AI #Pharma #LifeSciences